Off the wire
• FTSE 100 closes higher on Monday  • Finland confirms to join China-proposed investment bank  • 1st LD Writethru: Iran nuclear negotiators still finding solutions for remaining sticking points: Chinese FM  • Saudi-led coalition against Houthis takes control of Yemen's sea ports  • UN calls for speeding up actions on water management  • French stock market index up 0.98 pct on Monday  • Israeli PM warns world countries over Iran deal as agreement deadline looms  • NATO troops practice response to chemical weapons attack  • Returning tourists arrested in north Russia on attempt to smuggle cocaine  • Update: Bomb alert negative, Turkish plane allowed to continue trip  
You are here: 　 Home

EU approves acquisition of orthopaedic implants producer Biomet

Xinhua, March 31, 2015 Adjust font size:

The European Commission on Monday approved under the EU Merger Regulation the proposed acquisition of Biomet Inc. by its American counterpart Zimmer Holdings Inc..

Both companies produce orthopaedic implants and related surgical products. The approval is conditional upon a commitments package submitted by Zimmer.

The Commission had concerns that the merger, as initially notified, could have resulted in price increases for a number of orthopaedic implants in the European Economic Area (EEA). The commitments offered by Zimmer remove these concerns.

"Orthopaedic implants affect the mobility and quality of life of thousands of people across Europe. The remedies obtained by the Commission will ensure that patients continue to benefit from sufficient choice and innovation and that healthcare providers enjoy competitive prices." said Margrethe Vestager, the EU's Commissioner in charge of competition policy. Endit